IVIRMA Global Research Alliance, IVI Foundation - Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia 46026, Spain.
IVIRMA Global Research Alliance, IVIRMA Valencia, Valencia 46015, Spain.
Aging (Albany NY). 2023 Dec 26;15(24):14553-14573. doi: 10.18632/aging.205400.
Patients with poor ovarian response (POR) and premature ovarian insufficiency (POI) are challenging to treat, with oocyte donation remaining as the only feasible option to achieve pregnancy in some cases. The Autologous stem cell ovarian transplantation (ASCOT) technique allows follicle development, enabling pregnancies and births of healthy babies in these patients. Previous results suggest that growth factors and cytokines secreted by stem cells are partially responsible for their regenerative properties. Indeed, ASCOT beneficial effects associate with the presence of different bone marrow derived stem cell- secreted factors in plasma. Therefore, the aim of this study was to assess whether ASCOT induce any modifications in the plasma proteomic profile of patients with impaired ovarian reserves. Discriminant analysis highlighted clear distinctions between the plasma proteome before (PRE), during stem cell mobilization and collection (APHERESIS) and three months after ASCOT (POST) in patients with POR and POI. Both the stem cell mobilization and ASCOT technique induced statistically significant modifications in the plasma composition, reversing some age-related protein expression changes. In the POR group, functional analysis revealed an enrichment in processes related to the complement cascade, immune system, and platelet degranulation, while in the POI group, enriched processes were also associated with responses to oxygen-containing compounds and growth hormones, and blood vessel maturation. In conclusion, our findings highlight the potential proteins and biological processes that may promote the follicle activation and growth observed after ASCOT. Identifying plasma proteins that regenerate aged or damaged ovaries could lead to more effective, targeted and/or preventive therapies for patients.
对于卵巢反应不良(POR)和卵巢早衰(POI)患者的治疗具有挑战性,在某些情况下,卵母细胞捐赠仍然是实现妊娠的唯一可行选择。自体干细胞卵巢移植(ASCOT)技术允许卵泡发育,使这些患者能够怀孕并生育健康的婴儿。先前的结果表明,干细胞分泌的生长因子和细胞因子部分负责其再生特性。事实上,ASCOT 的有益效果与不同骨髓来源的干细胞分泌因子在血浆中的存在有关。因此,本研究旨在评估 ASCOT 是否会引起卵巢储备受损患者血浆蛋白质组谱的任何变化。判别分析突出了 POR 和 POI 患者在干细胞动员和采集(APHERESIS)前(PRE)、期间以及 ASCOT 后三个月(POST)的血浆蛋白质组之间的明显区别。干细胞动员和 ASCOT 技术都在统计学上显著改变了血浆成分,逆转了一些与年龄相关的蛋白表达变化。在 POR 组中,功能分析显示与补体级联、免疫系统和血小板脱颗粒相关的过程富集,而在 POI 组中,富集的过程也与对含氧量化合物和生长激素的反应以及血管成熟有关。总之,我们的研究结果强调了可能促进 ASCOT 后观察到的卵泡激活和生长的潜在蛋白和生物学过程。鉴定出可使衰老或受损卵巢再生的血浆蛋白,可能为患者带来更有效、有针对性和/或预防性的治疗方法。